共 34 条
- [1] 45, 10, pp. 241-247, (2020)
- [2] Yu F, Zhang Z, Luo L, Et al., Identification and molecular docking study of a novel angiotensin-i converting enzyme inhibitory peptide derived from enzymatic hydrolysates of cyclina sinensis[J], Marine Drugs, 16, 11, (2018)
- [3] Kaiser S, Martin M, Lunow D, Et al., Tryptophan-containing dipeptides are bioavailable and inhibit plasma human angiotensin-converting enzyme in vivo[J], International Dairy Journal, 52, pp. 107-114, (2016)
- [4] 34, 9, (2013)
- [5] Bernstein K E, Shen X Z, Gonzalez-Villalobos R A, Et al., Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE)[J], Current Opinion in Pharmacology, 11, 2, pp. 105-111, (2011)
- [6] Regulska K, Stanisz B, Regulski M, Et al., How to design a potent, specific, and stable angiotensin-converting enzyme inhibitor [J], Drug Discovery Today, 19, 11, pp. 1731-1743, (2014)
- [7] Bernstein K E, Ong F S, Blackwell W B, Et al., A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme[J], Pharmacological Reviews, 65, 1, pp. 1-46, (2013)
- [8] Wu J, Aluko R E, Nakai S., Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship modeling of peptides containing 4-10 amino acid residues[J], QSAR & Combinatorial Science, 25, 10, pp. 873-880, (2006)
- [9] (2018)
- [10] 29, 1, pp. 16-22, (2020)